FDA issued a Warning Letter to Sandoz Private Limited on 10/22/2015 for a previous inspection.
483 Sandoz Private Apr 2019

483 Sandoz Private Apr 2019

Yasamin Ameri FDA$119.00 - Available Now

FDA investigators audited the Sandoz Private - Navi Mumbai, India facility and issued inspectional observations (via FDA 483) on 12 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Apr 2019
  • Location: Navi Mumbai, India
  • FEI: 3004944629
Add To Cart